Tuberculosis: Pathogenesis, Current Treatment Regimens and New Drug Targets
Shahinda S. R. Alsayed, Hendra Gunosewoyo · International Journal of Molecular Sciences · 2023 · Review
Full textCC BY
Infectious Diseases
Filters2 filters applied
Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections
Matthew S. Linz, Arun Mattappallil, Diana Finkel et al. · Antibiotics · 2023 · Review
Full textCC BY
The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu et al. · Frontiers in Immunology · 2023 · Review
Full textCC BY
Antifungal Drug Resistance: An Emergent Health Threat
Antonio Vitiello, Francesco Ferrara, Mariarosaria Boccellino et al. · Biomedicines · 2023 · Review
Full textCC BY
Diagnosis of invasive fungal infections: challenges and recent developments
Wenjie Fang, Junqi Wu, Mingrong Cheng et al. · Journal of Biomedical Science · 2023 · Review
Full textCC BY
Pathogenicity and virulence of Mycobacterium tuberculosis
Kathryn C. Rahlwes, Beatriz R.S. Dias, Priscila C. Campos et al. · Virulence · 2023 · Review
Full textCC BY
Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis
Weijing Shang, Liangyu Kang, Guiying Cao et al. · Vaccines · 2022 · Review
Full textCC BY
Echinocandins – structure, mechanism of action and use in antifungal therapy
Mateusz Szymański, Sandra Chmielewska, Urszula Czyżewska et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2022 · Review
Full textCC BY
SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
Suresh Thakur, Shalitha Sasi, Sindhu Gopinathan Pillai et al. · Frontiers in Medicine · 2022 · Review
Full textCC BY
Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
Lok Bahadur Shrestha, Charles Foster, William Rawlinson et al. · Reviews in Medical Virology · 2022 · Review
Full textCC BY
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu et al. · Signal Transduction and Targeted Therapy · 2022 · Review
Full textCC BY
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei-Min Lu, Mu-Chun Li et al. · Journal of Biomedical Science · 2022 · Review
Full textCC BY
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Teny M. John, Ceena N. Jacob, Dimitrios P. Kontoyiannis · Journal of Fungi · 2021 · Review
Full textCC BY
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Ayslan Castro Brant, Wei Tian, Vladimir Majerciak et al. · Cell & Bioscience · 2021 · Review
Full textCC BY
Epidemiology of Mucormycosis in India
Hariprasath Prakash, Arunaloke Chakrabarti · Microorganisms · 2021 · Review
Full textCC BY
The Role of Th17 Response in COVID-19
Diana Martonik, Anna Parfieniuk-Kowerda, Magdalena Rogalska et al. · Cells · 2021 · Review
Full textCC BY
Persistence of Pathogens on Inanimate Surfaces: A Narrative Review
Jan Erik Wißmann, Lisa Kirchhoff, Yannick Brüggemann et al. · Microorganisms · 2021 · Review
Full textCC BY
SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns
Natalia Redondo, Sara Zaldívar-López, Juan J. Garrido et al. · Frontiers in Immunology · 2021 · Review
Full textCC BY
Obesity and COVID-19: what makes obese host so vulnerable?
Sameer Mohammad, Rafia Aziz, Saeed Al Mahri et al. · Immunity & Ageing · 2021 · Review
Abstract only
COVID-19 vaccines
Duduzile Ndwandwe, Charles S Wiysonge · Current Opinion in Immunology · 2021 · Review
Abstract only